Problems in the interpretation of serological results of hepatitis B testing during an incident of hepatitis B virus reactivation in a dialysis unit.

F. Fitzpatrick,M. Crean,G. Kaminski,J. Connell,L. Thornton,N. Murphy,A. Brennan,J. Walsh,H. Humphreys,E. Smyth
DOI: https://doi.org/10.1086/523274
2007-12-01
Infection Control and Hospital Epidemiology
Abstract:TO THE E D I T O R — I n April 2005, a case of reactivation of hepatitis B virus (HBV) infection occurred in a hemodialysis patient in an Irish tertiary referral center. In the absence of specific Irish dialysis guidelines at this time, most Irish units, including this center, followed UK guidelines; that is, HBV surface antigen (HBsAg) testing was performed prior to dialysis and then monthly, ideally, but at least every 3 months. The majority of units did not test for HBV core antibody (anti-HBc). This patient had tested negative for HBsAg prior to dialysis in November 2004 and was found to be HBsAg positive in April 2005. The patient became immunosuppressed over this period. Testing of an archived sample obtained prior to dialysis (November 2004) revealed that it was positive for anti-HBc. The April 2005 sample was positive for anti-HBc and negative for anti-HBc immunoglobulin (Ig) M.
What problem does this paper attempt to address?